Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.

Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...

The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...

Eddie Finlan (71) says the choir has lifted his spirits. “I was very ill last year and have lost a lot of weight. I was never ...

New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...

Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...

Short-course fluoroquinolone treatment is as effective as the conventional 7-day course for acute exacerbations of chronic ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as ...